Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guillermo Garcia-Manero

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia

English

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

Clinical Lymphoma, Myeloma and Leukemia

English

Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

Clinical Lymphoma, Myeloma and Leukemia

English

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Clinical Lymphoma, Myeloma and Leukemia

English

Acute Myeloid Leukemia With T(10;11): A Pathological Entity With Distinct Clinical Presentation

Clinical Lymphoma, Myeloma and Leukemia

English

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Clinical Lymphoma, Myeloma and Leukemia

English

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Clinical Lymphoma, Myeloma and Leukemia

English

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Clinical Lymphoma, Myeloma and Leukemia

English

A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis

Clinical Lymphoma, Myeloma and Leukemia

English

Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guillermo Garcia-Manero

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies

Acute Myeloid Leukemia With T(10;11): A Pathological Entity With Distinct Clinical Presentation

Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study

Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis

Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia